|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the KNSY 10-Q filed May 11, 2009. Note 7 – Goodwill The Company accounts for goodwill under the provisions of SFAS 142, Goodwill and Other Intangible Assets (SFAS 142). Under SFAS 142, goodwill is not amortized but is subject to annual impairment tests. The Company has established its annual impairment testing date as June 30 of each fiscal year. The most recent tests as of June 30, 2008, 2007 and 2006 indicated that goodwill was not impaired. Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, and from MacroPore, acquired in May 2007 (See Note 6). The net carrying amount of goodwill at March 31, 2009 was $4,366,273 and remained unchanged from the year ended June 30, 2008. This excerpt taken from the KNSY 10-Q filed Feb 9, 2009. Note 7 - Goodwill The Company accounts for goodwill under the provisions of SFAS 142, Goodwill and Other Intangible Assets (FAS 142). Under SFAS 142, goodwill is not amortized but is subject to annual impairment tests. The Company has established its annual impairment testing date as June 30 of each fiscal year. The most recent tests as of June 30, 2008, 2007 and 2006 indicated that goodwill was not impaired. Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, and from MacroPore, acquired in May 2007 (See Note 6). The net carrying amount of $4,366,273 for goodwill remained unchanged for the period ended December 31, 2008 from the year ended June 30, 2008.
12
Table of ContentsThis excerpt taken from the KNSY 10-Q filed Nov 10, 2008. Note 7 – Goodwill The Company accounts for goodwill under the provisions of SFAS 142, Goodwill and Other Intangible Assets (FAS 142). Under SFAS 142, goodwill is not amortized but is subject to annual impairment tests. The Company has established its annual impairment testing date as June 30 of each fiscal year. The most recent tests as of June 30, 2008, 2007 and 2006 indicated that goodwill was not impaired. Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, and from MacroPore, acquired in May 2007 (See Note 6). The net carrying amount of goodwill remained unchanged for the period ended September 30, 2008 from the year ended June 30, 2008. The balance as of September 30, 2008 was $4,366,273. This excerpt taken from the KNSY 10-Q filed May 9, 2008. Note 7 – Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, as well as certain assets acquired from ILT, in May 2006 (See Note 6) and from MacroPore, in May 2007 (See Note 6). Under SFAS 142, Goodwill and Other Intangible Assets (FAS 142), goodwill is not amortized, but is subject to annual impairment tests, which the Company has set to occur on June 30th of each fiscal year. Annual impairment tests in fiscal 2007, 2006, and 2005 indicated that goodwill was not impaired on the test date. The net carrying amount of goodwill increased for the period ended March 31, 2008 from the year ended June 30, 2007 by approximately $52,000, as a result of additional costs and allocations related to the acquisition of certain assets of MacroPore (See Note 6). This amount is expected to be fully deductible for tax purposes. The following table indicates the Company’s total goodwill balances as of the dates presented:
12
Table of ContentsThis excerpt taken from the KNSY 10-Q filed Feb 11, 2008. Note 7 – Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, as well as certain assets acquired from ILT, in May 2006 (See Note 6) and from MacroPore, in May 2007 (See Note 6). Under SFAS 142, Goodwill and Other Intangible Assets (FAS 142), goodwill is not amortized, but is subject to annual impairment tests, which the Company has set to occur on June 30th of each fiscal year. Annual impairment tests in fiscal 2007, 2006, and 2005 indicated that goodwill was not impaired on the test date. The net carrying amount of goodwill increased for the period ended December 31, 2007 from the year ended June 30, 2007 by approximately $52,000, as a result of additional costs and allocations related to the acquisition of certain assets of MacroPore (See Note 6). This amount is expected to be fully deductible for tax purposes. The following table indicates the Company’s total goodwill balances as of the dates presented:
This excerpt taken from the KNSY 10-Q filed Nov 9, 2007. Note 7 – Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, as well as certain assets acquired from ILT, in May 2006 (See Note 6) and from MacroPore, in May 2007 (See Note 6). All of the acquisitions were accounted for under SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142). Under SFAS 142, goodwill is not amortized, but is subject to annual impairment tests, which the Company has set to occur on June 30th of each fiscal year. Annual impairment tests in fiscal 2007, 2006, and 2005 indicated that goodwill was not impaired on the test date. The net carrying amount of goodwill increased for the quarter ended September 30, 2007 from the year ended June 30, 2007 by approximately $52,000, related to additional costs and allocations related to the acquisition of certain assets of MacroPore (See Note 6). This amount is expected to be fully deductible for tax purposes. The following table indicates the Company’s total goodwill balances as of the dates presented:
12
Table of ContentsThis excerpt taken from the KNSY 10-Q filed May 10, 2007. Note 7 – Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM, a company acquired in September 2000, and of certain identifiable net assets of ILT, acquired in May 2006. Both acquisitions were accounted for under SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142).
11
Under SFAS 142, goodwill is not amortized but is subject to annual impairment tests, which the Company has set to occur on June 30th of each fiscal year. Annual impairment tests in fiscal 2006, 2005 and 2004 indicated that goodwill was not impaired on the test date. Goodwill related to the acquisition of certain assets ILT totaled $6.2 million, an amount that is expected to be fully deductible for tax purposes. The following table indicates the Company’s total goodwill balances as of the dates presented:
This excerpt taken from the KNSY 10-Q filed Feb 9, 2007. Note 7 – Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM Biomedical (THM), a company acquired in September 2000, and of the identifiable net assets of ILT, acquired in May 2006. Both acquisitions were accounted for under SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142). Under SFAS 142, goodwill is no longer amortized but is subject to annual impairment tests, which the Company has set to be June 30th of each fiscal year. Annual impairment tests in fiscal 2006, 2005 and 2004 indicated that goodwill was not impaired on the annual date.
11
Table of ContentsGoodwill related to the acquisition of ILT totaled $6.4 million, an amount that is expected to be fully deductible for tax purposes. The following table indicates the Company’s total goodwill balances as of the dates presented:
This excerpt taken from the KNSY 10-Q filed Nov 9, 2006. Note 7 - Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM Biomedical (THM), a company acquired in September 2000, and of the identifiable net assets of ILT, acquired in May 2006. Both acquisitions were accounted for under SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142).
11
Table of ContentsUnder SFAS 142, goodwill is no longer amortized but is subject to annual impairment tests, which the Company has set to be June 30th of each fiscal year. Annual impairment tests in fiscal 2006, 2005 and 2004 indicated that goodwill was not impaired on the annual date. Goodwill related to the acquisition of ILT totaled $6.4 million, an amount that is expected to be fully deductible for tax purposes. The following table indicates the Company’s total goodwill balances as of the dates presented:
This excerpt taken from the KNSY 10-K filed Sep 13, 2006. 3. GOODWILL The Company accounts for goodwill under the provisions of SFAS 142. Under SFAS 142, goodwill is no longer amortized but is subject to annual impairment tests. The Company has established its annual impairment testing date to be June 30th of each fiscal year. The Company completed its initial required goodwill impairment test under SFAS 142 in the first quarter of fiscal 2002. The net carrying amount of goodwill increased by $6.3 million for the year ended June 30, 2006 from June 30, 2005 related to the acquisition of ILT (See Note 21). The most recent tests in fiscal 2006, 2005 and 2004 indicated that goodwill was not impaired.
This excerpt taken from the KNSY 10-Q filed May 10, 2006. Goodwill Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM Biomedical, Inc. (THM), a company acquired in September 2000. Effective July 1, 2001, the Company adopted SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142). SFAS 141 requires that the purchase method of accounting be used for all business combinations subsequent to June 30, 2001 and specifies criteria for recognizing intangible assets acquired in a business combination. Under SFAS 142, goodwill and intangible assets with indefinite useful lives are no longer amortized, but are subject to annual impairment tests. Intangible assets with definite useful lives continue to be amortized over their respective useful lives. Adoption of SFAS 142 did not result in the reclassification of any intangible assets, changes in the amortization periods for those intangible assets with definite lives or the impairment of any intangible assets. There were no changes to the net carrying amount of goodwill at March 31, 2006 from June 30, 2005. The Company completed its initial required goodwill impairment test under SFAS 142 in the first quarter of fiscal 2002. The most recent tests in fiscal 2005, 2004 and 2003 indicated that goodwill was not impaired. This excerpt taken from the KNSY 10-Q filed Feb 9, 2006. Goodwill
Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM Biomedical, Inc. (THM), a company acquired in September 2000. Effective July 1, 2001, the Company adopted SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142). SFAS 141 requires that the purchase method of accounting be used for all business combinations subsequent to June 30, 2001 and specifies criteria for recognizing intangible assets acquired in a business combination. Under SFAS 142, goodwill and intangible assets with indefinite useful lives are no longer amortized, but are subject to annual impairment tests. Intangible assets with definite useful lives continue to be amortized over their respective useful lives. Adoption of SFAS 142 did not result in the reclassification of any intangible assets, changes in the amortization periods for those intangible assets with definite lives or the impairment of any intangible assets.
There were no changes to the net carrying amount of goodwill at December 31, 2005 from June 30, 2005. The Company completed its initial required goodwill impairment test under SFAS 142 in the first quarter of fiscal 2002. The most recent tests in fiscal 2005, 2004 and 2003 indicated that goodwill was not impaired.
This excerpt taken from the KNSY 10-Q filed Nov 9, 2005. Goodwill
Goodwill represents the excess of cost over the fair market value of the identifiable net assets of THM Biomedical, Inc. (THM), a company acquired in September 2000. Effective July 1, 2001, the Company adopted SFAS No. 141, Business Combinations (SFAS 141) and SFAS No. 142, Goodwill and Other Intangible Assets (SFAS 142). SFAS 141 requires that the purchase method of accounting be used for all business combinations subsequent to June 30, 2001 and specifies criteria for recognizing intangible assets acquired in a business combination. Under SFAS 142, goodwill and intangible assets with indefinite useful lives are no longer amortized, but are subject to annual impairment tests. Intangible assets with definite useful lives continue to be amortized over their respective useful lives. Adoption of SFAS 142 did not result in the reclassification of any intangible assets, changes in the amortization periods for those intangible assets with definite lives or the impairment of any intangible assets.
There were no changes to the net carrying amount of goodwill at September 30, 2005 from June 30, 2005. The Company completed its initial required goodwill impairment test under SFAS 142 in the first quarter of fiscal 2002. The most recent tests in fiscal 2005, 2004 and 2003 indicated that goodwill was not impaired.
This excerpt taken from the KNSY 10-K filed Sep 13, 2005. 3. GOODWILL
The Company accounts for goodwill under the provisions of SFAS 142. Under SFAS 142, goodwill is no longer amortized but is subject to annual impairment tests. The Company has established its annual impairment testing date to be June 30th of each fiscal year.
There were no changes to the net carrying amount of goodwill for the year ended June 30, 2005 from June 30, 2004. The Company completed its initial required goodwill impairment test under SFAS 142 in the first quarter of fiscal 2002. The most recent tests in fiscal 2005, 2004 and 2003 indicated that goodwill was not impaired.
| EXCERPTS ON THIS PAGE: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
